Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)
Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%
Zimmer Biomet r&d expenses
Research and development expenses are spending on new products and technology.
Zimmer Biomet's R&D Expenses for the twelve months ending Jun 30, 2026 was $442.80M, down 0.3% year over year. For fiscal 2025 it was $458.50M, up 4.8% from the year before. Over ten years it grew 5.5% a year on average. The highest annual figure on record is $458.70M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $458.50M | +4.8% |
| FY2024 | Dec 31, 2024 | $437.40M | -4.6% |
| FY2023 | Dec 31, 2023 | $458.70M | +13.0% |
| FY2022 | Dec 31, 2022 | $406.00M | -6.8% |
| FY2021 | Dec 31, 2021 | $435.80M | +35.0% |
| FY2020 | Dec 31, 2020 | $322.80M | -28.2% |
| FY2019 | Dec 31, 2019 | $449.30M | +14.7% |
| FY2018 | Dec 31, 2018 | $391.70M | +5.9% |
| FY2017 | Dec 31, 2017 | $369.90M | +1.2% |
| FY2016 | Dec 31, 2016 | $365.60M | +36.0% |
| FY2015 | Dec 31, 2015 | $268.80M | +43.4% |
| FY2014 | Dec 31, 2014 | $187.40M | -7.7% |
| FY2013 | Dec 31, 2013 | $203.00M | -10.0% |
| FY2012 | Dec 31, 2012 | $225.60M | -5.4% |
| FY2011 | Dec 31, 2011 | $238.40M | +9.1% |
| FY2010 | Dec 31, 2010 | $218.50M | +6.2% |
| FY2009 | Dec 31, 2009 | $205.70M | +7.0% |
| FY2008 | Dec 31, 2008 | $192.30M | +5.3% |
| FY2007 | Dec 31, 2007 | $182.60M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $104.80M | -7.5% |
| Q1 FY2026 | Mar 31, 2026 | $103.40M | -6.5% |
| Q4 FY2025 | Dec 31, 2025 | $118.70M | +9.4% |
| Q3 FY2025 | Sep 30, 2025 | $115.90M | +3.9% |
| Q2 FY2025 | Jun 30, 2025 | $113.30M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | $110.60M | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $108.50M | -4.2% |
| Q3 FY2024 | Sep 30, 2024 | $111.60M | -4.5% |
| Q2 FY2024 | Jun 30, 2024 | $109.40M | -7.4% |
| Q1 FY2024 | Mar 31, 2024 | $107.90M | -2.3% |
| Q4 FY2023 | Dec 31, 2023 | $113.30M | +4.9% |
| Q3 FY2023 | Sep 30, 2023 | $116.90M | +14.9% |
| Q2 FY2023 | Jun 30, 2023 | $118.10M | +18.8% |
| Q1 FY2023 | Mar 31, 2023 | $110.40M | +13.9% |
| Q4 FY2022 | Dec 31, 2022 | $108.00M | +12.5% |
| Q3 FY2022 | Sep 30, 2022 | $101.70M | +8.4% |
| Q2 FY2022 | Jun 30, 2022 | $99.40M | -39.8% |
| Q1 FY2022 | Mar 31, 2022 | $96.90M | +19.6% |
| Q4 FY2021 | Dec 31, 2021 | $96.00M | +89.0% |
| Q3 FY2021 | Sep 30, 2021 | $93.80M | +9.2% |
| Q2 FY2021 | Jun 30, 2021 | $165.00M | +88.1% |
| Q1 FY2021 | Mar 31, 2021 | $81.00M | -17.7% |
| Q4 FY2020 | Dec 31, 2020 | $50.80M | -58.1% |
| Q3 FY2020 | Sep 30, 2020 | $85.90M | -24.9% |
| Q2 FY2020 | Jun 30, 2020 | $87.70M | -21.8% |
| Q1 FY2020 | Mar 31, 2020 | $98.40M | -3.2% |
| Q4 FY2019 | Dec 31, 2019 | $121.10M | +19.7% |
| Q3 FY2019 | Sep 30, 2019 | $114.40M | +19.5% |
| Q2 FY2019 | Jun 30, 2019 | $112.10M | +13.1% |
| Q1 FY2019 | Mar 31, 2019 | $101.70M | +6.3% |
| Q4 FY2018 | Dec 31, 2018 | $101.20M | +6.5% |
| Q3 FY2018 | Sep 30, 2018 | $95.70M | +4.9% |
| Q2 FY2018 | Jun 30, 2018 | $99.10M | +7.0% |
| Q1 FY2018 | Mar 31, 2018 | $95.70M | +5.0% |
| Q4 FY2017 | Dec 31, 2017 | $95.00M | -0.7% |
| Q3 FY2017 | Sep 30, 2017 | $91.20M | -4.6% |
| Q2 FY2017 | Jun 30, 2017 | $92.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $91.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $95.70M | – |
| Q3 FY2016 | Sep 30, 2016 | $95.60M | – |
See a number that looks wrong?